Literature DB >> 3743618

Analysis of phenylephrine in plasma: initial data about the concentration-effect relationship.

A Martinsson, S Bevegård, P Hjemdahl.   

Abstract

A simple and sensitive assay for phenylephrine in plasma using HPLC with electrochemical detection is presented. Infusion of phenylephrine hydrochloride 0.5, 1.0, 2.0, and 4.0 micrograms X kg-1 X min-1 for 6 min at each dose level to 9 healthy subjects resulted in mean venous plasma concentrations of phenylephrine of 20, 56, 118 and 308 nM, respectively. The systolic and diastolic blood pressures were increased and the heart rate and venous plasma noradrenaline levels fell with increasing phenylephrine concentrations. There was a more than two-fold interindividual variation in the plasma concentration during infusion of the standardized doses of phenylephrine, with overlap of the concentrations achieved at the different dose levels. Estimates of the sensitivity to phenylephrine showed discrepancies within individuals when expressed as the concentration (PC20) or dose (PD20) required to increase systolic blood pressure by 20 mm Hg. Thus, evaluation of concentration-response curves should be more reliable than of dose-response curves when assessing phenylephrine sensitivity during i.v. infusions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3743618     DOI: 10.1007/bf00607955

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method.

Authors:  P Hjemdahl; M Daleskog; T Kahan
Journal:  Life Sci       Date:  1979-07-09       Impact factor: 5.037

Review 2.  Systemic arterial baroreceptor reflexes.

Authors:  H R Kirchheim
Journal:  Physiol Rev       Date:  1976-01       Impact factor: 37.312

3.  GLC determination of phenylephrine hydrochloride in human plasma.

Authors:  L J Dombrowski; P M Comi; E L Pratt
Journal:  J Pharm Sci       Date:  1973-11       Impact factor: 3.534

4.  Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion.

Authors:  P Hjemdahl; T Akerstedt; T Pollare; M Gillberg
Journal:  Acta Physiol Scand Suppl       Date:  1983

5.  Simultaneous stability-indicating determination of phenylephrine hydrochloride, phenylpropanolamine hydrochloride, and guaifenesin in dosage forms by reversed-phase paired-ion high-performance liquid chromatography.

Authors:  G W Schieffer; D E Hughes
Journal:  J Pharm Sci       Date:  1983-01       Impact factor: 3.534

Review 6.  Catecholamine measurements by high-performance liquid chromatography.

Authors:  P Hjemdahl
Journal:  Am J Physiol       Date:  1984-07

7.  Concurrent antagonism of isoproterenol and norepinephrine after labetalol.

Authors:  D A Richards; B N Prichard
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

8.  Pharmacokinetics of 3H-phenylephrine in man.

Authors:  J H Hengstmann; J Goronzy
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Alpha-receptor function changes after the first dose of prazosin.

Authors:  C von Bahr; B Lindström; P Seideman
Journal:  Clin Pharmacol Ther       Date:  1982-07       Impact factor: 6.875

10.  Effect of age on the responsiveness of vascular alpha-adrenoceptors in man.

Authors:  H L Elliott; D J Sumner; K McLean; J L Reid
Journal:  J Cardiovasc Pharmacol       Date:  1982 May-Jun       Impact factor: 3.105

View more
  3 in total

Review 1.  The pressor dose-response in clinical cardiovascular pharmacology.

Authors:  D J Sumner; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

2.  Atrial natriuretic factor and autonomic nervous system function in man.

Authors:  P Ferrari; C P Ferrier; L Franscini; H Saxenhofer; S Shaw; P Weidmann
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Safety, Pharmacokinetic, and Pharmacodynamic Study of a Sublingual Formula for the Treatment of Vasovagal Syncope.

Authors:  Paul Hutson; Regis Guieu; Jean-Claude Deharo; Pierre Michelet; Michele Brignole; Cassondra Vander Ark; Mohamed H Hamdan
Journal:  Drugs R D       Date:  2022-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.